Acurx Pharmaceuticals
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Acurx Pharmaceuticals's balance sheet done over the years? Its assets were worth $7,709,123 last year, which is less than in the previous period. 39% of Acurx Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $3,042,438, which means an increase by 48% compared compared to last year.
Debt to Assets
| 2019 | 2531425 | 1.71M | 67.61% |
|---|---|---|---|
| 2020 | 3224020 | 522.43K | 16.2% |
| 2021 | 13254150 | 843.90K | 6.37% |
| 2022 | 9376706 | 2.06M | 21.99% |
| 2023 | 7709123 | 3.04M | 39.47% |
ACXP Balance Sheet (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Assets | |||||
Current assets: | |||||
Cash and cash equivalents | 7.47M | 9.11M | 12.95M | 3.17M | 2.48M |
Short term investments | 0 | 0 | 0 | 0 | 0 |
Net receivables | 129.15K | 0 | 0 | 0 | 0 |
Inventory | 0 | 0 | 0 | 0 | 0 |
Other current assets | 105.77K | 264.95K | 295.30K | 48.60K | 48.10K |
Total current assets | 7.70M | 9.37M | 13.25M | 3.22M | 2.53M |
Non-current assets: | |||||
Property, Plant and Equipment | 0 | 0 | 0 | 0 | 0 |
Goodwill | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 0 | 0 | 0 |
Long term investments | 0 | 0 | 0 | 0 | 0 |
Other non-current assets | 0 | 0 | 0 | 0 | 0 |
Total non-current assets | 0 | 0 | 0 | 0 | 0 |
Total assets | 7.70M | 9.37M | 13.25M | 3.22M | 2.53M |
Liabilities | |||||
| Current liabilities: | |||||
Accounts payable | |||||
Deferred revenue | 0 | 0 | 0 | 0 | 0 |
Short term debt | 0 | 0 | 0 | 16.62K | 0 |
Total current liabilities | 3.04M | 2.06M | 843.90K | 472.55K | 1.71M |
| Non-current liabilities: | |||||
Long term debt | 0 | 0 | 0 | 49.87K | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 0 | 2.06M | 0 | -1 | 0 |
Total non-current liabilities | 0 | 2.06M | 0 | 49.87K | 0 |
Total liabilities | 3.04M | 2.06M | 843.90K | 522.43K | 1.71M |
| Data source | Data source | Data source |